ATE412423T1 - Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion - Google Patents
Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektionInfo
- Publication number
- ATE412423T1 ATE412423T1 AT02731136T AT02731136T ATE412423T1 AT E412423 T1 ATE412423 T1 AT E412423T1 AT 02731136 T AT02731136 T AT 02731136T AT 02731136 T AT02731136 T AT 02731136T AT E412423 T1 ATE412423 T1 AT E412423T1
- Authority
- AT
- Austria
- Prior art keywords
- infection
- peroxiredoxin
- drugs
- treating hiv
- hiv
- Prior art date
Links
- 208000031886 HIV Infections Diseases 0.000 title abstract 4
- 102000007456 Peroxiredoxin Human genes 0.000 title abstract 2
- 108030002458 peroxiredoxin Proteins 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01015—Peroxiredoxin (1.11.1.15)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27823401P | 2001-03-23 | 2001-03-23 | |
| US10/057,593 US20020168353A1 (en) | 2001-03-23 | 2002-01-25 | Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412423T1 true ATE412423T1 (de) | 2008-11-15 |
Family
ID=26736676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02731136T ATE412423T1 (de) | 2001-03-23 | 2002-03-18 | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20020168353A1 (de) |
| EP (1) | EP1370697B1 (de) |
| AT (1) | ATE412423T1 (de) |
| DE (1) | DE60229624D1 (de) |
| WO (1) | WO2002077294A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004043485A1 (en) * | 2002-11-10 | 2004-05-27 | Institute Of Cell Biophysics Russian Academy Of Sciences | Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| KR100610774B1 (ko) * | 2005-02-03 | 2006-08-28 | 이화여자대학교 산학협력단 | 퍼록시레독신 2 단백질을 유효성분으로 함유하는 혈관재협착 예방 및 치료용 약학조성물, 퍼록시레독신 2유전자 또는 그로부터 발현되는 단백질을 포함하는 혈관재협착 치료제 스크리닝용 조성물 및 이를 이용하는 혈관재협착 치료제 스크리닝 방법 |
| WO2011071992A1 (en) * | 2009-12-08 | 2011-06-16 | Health Research, Inc. | Inhibition of tumor angiogenesis by inhibition of peroxiredoxin 1 (prx1) |
| KR20130028044A (ko) * | 2009-12-08 | 2013-03-18 | 헬스 리서치 인코포레이티드 | 보조제로서 퍼옥시레독신1 (ｐｒｘ１)을 사용하는 방법 및 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610286A (en) * | 1991-11-04 | 1997-03-11 | The Regents Of The University Of California | DNA's encoding natural killer cell enhancing factor |
| US5250295A (en) * | 1991-11-04 | 1993-10-05 | The Regents Of The Univ. Of California | Natural killer cell enhancing factor |
| WO1996039424A1 (en) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Natural killer cell enhancing factor c |
| US6150135A (en) * | 1997-05-23 | 2000-11-21 | Heska Corporation | Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof |
-
2002
- 2002-01-25 US US10/057,593 patent/US20020168353A1/en not_active Abandoned
- 2002-03-18 EP EP02731136A patent/EP1370697B1/de not_active Expired - Lifetime
- 2002-03-18 AT AT02731136T patent/ATE412423T1/de not_active IP Right Cessation
- 2002-03-18 WO PCT/US2002/008077 patent/WO2002077294A1/en not_active Ceased
- 2002-03-18 DE DE60229624T patent/DE60229624D1/de not_active Expired - Fee Related
-
2005
- 2005-06-02 US US11/145,558 patent/US20060099199A1/en not_active Abandoned
-
2008
- 2008-08-20 US US12/195,103 patent/US20090246821A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060099199A1 (en) | 2006-05-11 |
| EP1370697A1 (de) | 2003-12-17 |
| WO2002077294A1 (en) | 2002-10-03 |
| US20020168353A1 (en) | 2002-11-14 |
| US20090246821A1 (en) | 2009-10-01 |
| EP1370697B1 (de) | 2008-10-29 |
| EP1370697A4 (de) | 2004-04-14 |
| DE60229624D1 (de) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| ATE377657T1 (de) | Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| DE60023043D1 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
| NO20034056D0 (no) | Proliferative sykdommer | |
| DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
| ATE448775T1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| SE0302304D0 (sv) | Novel compounds | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| ATE412423T1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
| ATE406171T1 (de) | Aplidine zur behandlung von multiplem myelom | |
| ATE253936T1 (de) | Glutathion-reduktase zur behandlung und prophylaxe von aids | |
| ATE545421T1 (de) | Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat | |
| DE60331654D1 (de) | Nicht-radioaktives Strontiummittel zur Behandlung von Krebs | |
| EP1261331A4 (de) | Methoden und zusammenstellungen zur behandlung von fibrotischen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |